The Leukemia & Lymphoma Society funds leading-edge research for every type of blood cancer, including leukemia, lymphoma, myeloma, and other rare types of blood cancers. As the largest nonprofit funder of cutting-edge blood cancer research to advance cures, LLS has invested more than $1.5 billion in cancer research since we started in 1949, leading to breakthroughs in immunotherapy, genomics and personalized medicine that are improving and saving the lives of patients.
In the last six years, LLS has helped advance more than 70% of the 110 blood cancer treatment options approved by the FDA.
I choose to support LLS because 75% of the funds that we raise through Team in Training go directly to fund research. Research that not only impacts blood cancer patients, but all cancer patients. The groundbreaking treatments and therapies that are funded by LLS save lives: plain and simple.
Here are some photos from the past 12 years that you just might enjoy...
